Target Name: Aldo-Keto Reductase Family 1
NCBI ID: P32794
Review Report on Aldo-Keto Reductase Family 1 Target / Biomarker Content of Review Report on Aldo-Keto Reductase Family 1 Target / Biomarker
Aldo-Keto Reductase Family 1
Other Name(s): None

Aldo-Keto Reductase Family 1 (nonspecific Subtype) Metabolizes Nucleotides

Aldo-Keto Reductase Family 1 (nonspecific subtype), also known as NAD+-dependent alkaline phosphatase, is a enzyme that plays a crucial role in various cellular processes. This enzyme is responsible for the metabolism of nucleotides, which are the building blocks of DNA and RNA. Aldo-Keto Reductase Family 1 is a subunit of the NAD+-dependent alkaline phosphatase enzyme complex, which is a complex that includes several different subunits that work together to catalyze the metabolism of nucleotides.

The Aldo-Keto Reductase Family 1 (nonspecific subtype) enzyme is a critical enzyme that is involved in the metabolism of nucleotides. This enzyme catalyzes the conversion of ADP+Pi to ATP+Pi, which is the process by which ATP is synthesized from ADP and Pi. The conversion of ADP+Pi to ATP+Pi is a critical step in the cell's energy metabolism and is essential for the proper functioning of many cellular processes.

Aldo-Keto Reductase Family 1 (nonspecific subtype) is a protein that is expressed in most tissues and cells of the body. This enzyme is primarily localized to the cytoplasm of cells, where it is involved in the metabolism of nucleotides. The cytoplasm is the fluid inside the cell that contains the cytoplasmic organelles, including the mitochondria, endoplasmic reticulum, and endoskeleton.

The Aldo-Keto Reductase Family 1 (nonspecific subtype) enzyme is a critical enzyme that is involved in the metabolism of nucleotides. This enzyme catalyzes the conversion of ADP+Pi to ATP+Pi, which is the process by which ATP is synthesized from ADP and Pi.

Aldo-Keto Reductase Family 1 (nonspecific subtype) is a protein that is expressed in most tissues and cells of the body. This enzyme is primarily localized to the cytoplasm of cells, where it is involved in the metabolism of nucleotides.

The Aldo-Keto Reductase Family 1 (nonspecific subtype) enzyme is a critical enzyme that is involved in the metabolism of nucleotides. This enzyme catalyzes the conversion of ADP+Pi to ATP+Pi, which is the process by which ATP is synthesized from ADP and Pi. The conversion of ADP+Pi to ATP+Pi is essential for the proper functioning of many cellular processes, including the regulation of gene expression, DNA replication, and protein synthesis.

In addition to its role in nucleotide metabolism, Aldo-Keto Reductase Family 1 (nonspecific subtype) is also involved in the regulation of cellular processes. This enzyme has been shown to play a role in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs.

The Aldo-Keto Reductase Family 1 (nonspecific subtype) enzyme is also involved in the regulation of cellular processes. This enzyme has been shown to play a role in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs.

Aldo-Keto Reductase Family 1 (nonspecific subtype) is a protein that is involved in the metabolism of nucleotides. This enzyme catalyzes the conversion of ADP+Pi to ATP+Pi, which is the process by which ATP is synthesized from ADP and Pi. The conversion of ADP+Pi to ATP+Pi is essential for the proper functioning of many cellular processes, including the regulation of gene expression, DNA replication, and protein synthesis.

In addition to its role in nucleotide metabolism, Aldo-Keto Reductase Family 1 (nonspecific subtype) is also involved in

Protein Name: Aldo-Keto Reductase Family 1 (nonspecified Subtype)

The "Aldo-Keto Reductase Family 1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Aldo-Keto Reductase Family 1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ALDOA | ALDOAP2 | ALDOB | ALDOC | ALG1 | ALG10 | ALG10B | ALG11 | ALG12 | ALG13 | ALG14 | ALG1L10P | ALG1L13P | ALG1L1P | ALG1L2 | ALG1L5P | ALG1L7P | ALG1L8P | ALG2 | ALG3 | ALG5 | ALG6 | ALG8 | ALG9 | ALK | ALKAL1 | ALKAL2 | Alkaline Phosphatase (ALP) | ALKBH1 | ALKBH2 | ALKBH3 | ALKBH4 | ALKBH5 | ALKBH6 | ALKBH7 | ALKBH8 | ALLC | ALMS1 | ALMS1-IT1 | ALMS1P1 | ALOX12 | ALOX12-AS1 | ALOX12B | ALOX12P2 | ALOX15 | ALOX15B | ALOX15P1 | ALOX15P2 | ALOX5 | ALOX5AP | ALOXE3 | ALPG | Alpha-2 Adrenergic receptors | alpha-6 beta-2 Nicotinic receptor | alpha-Adrenoceptor | alpha-Amylase | alpha-beta T Cell Receptor Complex (TCR) | Alpha-crystallin | alpha-Mannosidase | alpha-Secretase | alpha1-Adrenoceptor | ALPI | ALPK1 | ALPK2 | ALPK3 | ALPL | ALPP | ALS2 | ALS2CL | ALX1 | ALX3 | ALX4 | ALYREF | AMACR | AMBN | AMBP | AMBRA1 | AMD1 | AMD1P2 | AMDHD1 | AMDHD2 | AMELX | AMELY | AMER1 | AMER2 | AMER3 | AMFR | AMH | AMHR2 | AMIGO1 | AMIGO2 | AMIGO3 | Amine oxidase (copper containing) | Amino acid hydroxylase | Aminoacyl-tRNA Synthetase Complex | AMMECR1 | AMMECR1L | AMN | AMN1 | AMOT